id	sid	tid	token	lemma	pos
dpc-5139	1	1	dermatology	dermatology	NOUN
dpc-5139	1	2	:	:	PUNCT
dpc-5139	1	3	practical	practical	ADJ
dpc-5139	1	4	and	and	CCONJ
dpc-5139	1	5	conceptual	conceptual	ADJ
dpc-5139	1	6	research	research	NOUN
dpc-5139	1	7	letter	letter	NOUN
dpc-5139	2	1	|	|	ADV
dpc-5139	2	2	dermatol	dermatol	ADJ
dpc-5139	2	3	pract	pract	NOUN
dpc-5139	2	4	concept	concept	NOUN
dpc-5139	2	5	.	.	PUNCT
dpc-5139	3	1	2025;15(2):5139	2025;15(2):5139	NUM
dpc-5139	3	2	1	1	NUM
dpc-5139	3	3	upadacitinib	upadacitinib	NOUN
dpc-5139	3	4	for	for	ADP
dpc-5139	3	5	treatment	treatment	NOUN
dpc-5139	3	6	-	-	PUNCT
dpc-5139	3	7	resistant	resistant	ADJ
dpc-5139	3	8	urticarial	urticarial	NOUN
dpc-5139	3	9	vasculitis	vasculitis	NOUN
dpc-5139	3	10	:	:	PUNCT
dpc-5139	3	11	a	a	DET
dpc-5139	3	12	case	case	NOUN
dpc-5139	3	13	study	study	NOUN
dpc-5139	3	14	and	and	CCONJ
dpc-5139	3	15	therapeutic	therapeutic	ADJ
dpc-5139	3	16	insight	insight	NOUN
dpc-5139	3	17	francesca	francesca	PROPN
dpc-5139	3	18	falcinelli1	falcinelli1	PROPN
dpc-5139	3	19	,	,	PUNCT
dpc-5139	3	20	edoardo	edoardo	PROPN
dpc-5139	3	21	conticini2	conticini2	PROPN
dpc-5139	3	22	,	,	PUNCT
dpc-5139	3	23	luca	luca	PROPN
dpc-5139	3	24	cantarini2	cantarini2	PROPN
dpc-5139	3	25	,	,	PUNCT
dpc-5139	3	26	bruno	bruno	PROPN
dpc-5139	3	27	frediani2	frediani2	PROPN
dpc-5139	3	28	,	,	PUNCT
dpc-5139	3	29	pietro	pietro	PROPN
dpc-5139	3	30	rubegni1	rubegni1	PROPN
dpc-5139	3	31	,	,	PUNCT
dpc-5139	3	32	laura	laura	NOUN
dpc-5139	3	33	calabrese1,3	calabrese1,3	PROPN
dpc-5139	3	34	1	1	NUM
dpc-5139	3	35	dermatology	dermatology	NOUN
dpc-5139	3	36	unit	unit	NOUN
dpc-5139	3	37	and	and	CCONJ
dpc-5139	3	38	skin	skin	NOUN
dpc-5139	3	39	bank	bank	PROPN
dpc-5139	3	40	,	,	PUNCT
dpc-5139	3	41	department	department	NOUN
dpc-5139	3	42	of	of	ADP
dpc-5139	3	43	medical	medical	ADJ
dpc-5139	3	44	,	,	PUNCT
dpc-5139	3	45	surgical	surgical	ADJ
dpc-5139	3	46	and	and	CCONJ
dpc-5139	3	47	neurosciences	neuroscience	NOUN
dpc-5139	3	48	,	,	PUNCT
dpc-5139	3	49	siena	siena	PROPN
dpc-5139	3	50	university	university	PROPN
dpc-5139	3	51	hospital	hospital	NOUN
dpc-5139	3	52	,	,	PUNCT
dpc-5139	3	53	siena	siena	PROPN
dpc-5139	3	54	–	–	PUNCT
dpc-5139	3	55	italy	italy	PROPN
dpc-5139	3	56	2	2	NUM
dpc-5139	3	57	rheumatology	rheumatology	NOUN
dpc-5139	3	58	unit	unit	NOUN
dpc-5139	3	59	,	,	PUNCT
dpc-5139	3	60	department	department	NOUN
dpc-5139	3	61	of	of	ADP
dpc-5139	3	62	medicine	medicine	NOUN
dpc-5139	3	63	,	,	PUNCT
dpc-5139	3	64	surgery	surgery	NOUN
dpc-5139	3	65	and	and	CCONJ
dpc-5139	3	66	neurosciences	neuroscience	NOUN
dpc-5139	3	67	,	,	PUNCT
dpc-5139	3	68	university	university	PROPN
dpc-5139	3	69	of	of	ADP
dpc-5139	3	70	siena	siena	PROPN
dpc-5139	3	71	,	,	PUNCT
dpc-5139	3	72	italy	italy	PROPN
dpc-5139	3	73	3	3	NUM
dpc-5139	3	74	institute	institute	PROPN
dpc-5139	3	75	of	of	ADP
dpc-5139	3	76	dermatology	dermatology	NOUN
dpc-5139	3	77	,	,	PUNCT
dpc-5139	3	78	catholic	catholic	PROPN
dpc-5139	3	79	university	university	PROPN
dpc-5139	3	80	of	of	ADP
dpc-5139	3	81	the	the	DET
dpc-5139	3	82	sacred	sacred	ADJ
dpc-5139	3	83	heart	heart	NOUN
dpc-5139	3	84	,	,	PUNCT
dpc-5139	3	85	rome	rome	PROPN
dpc-5139	3	86	,	,	PUNCT
dpc-5139	3	87	italy	italy	PROPN
dpc-5139	3	88	citation	citation	PROPN
dpc-5139	3	89	:	:	PUNCT
dpc-5139	4	1	falcineli	falcineli	PROPN
dpc-5139	4	2	f	f	X
dpc-5139	4	3	,	,	PUNCT
dpc-5139	4	4	conticini	conticini	PROPN
dpc-5139	4	5	e	e	NOUN
dpc-5139	4	6	,	,	PUNCT
dpc-5139	4	7	cantarini	cantarini	PROPN
dpc-5139	4	8	l	l	PROPN
dpc-5139	4	9	,	,	PUNCT
dpc-5139	4	10	frediani	frediani	PROPN
dpc-5139	4	11	b	b	NUM
dpc-5139	4	12	,	,	PUNCT
dpc-5139	4	13	rubegni	rubegni	NOUN
dpc-5139	4	14	p	p	NOUN
dpc-5139	4	15	,	,	PUNCT
dpc-5139	4	16	calabrese	calabrese	ADJ
dpc-5139	4	17	l.	l.	NOUN
dpc-5139	4	18	upadacitinib	upadacitinib	NOUN
dpc-5139	4	19	for	for	ADP
dpc-5139	4	20	treatment	treatment	NOUN
dpc-5139	4	21	-	-	PUNCT
dpc-5139	4	22	resistant	resistant	ADJ
dpc-5139	4	23	urticarial	urticarial	NOUN
dpc-5139	4	24	vasculitis	vasculitis	NOUN
dpc-5139	4	25	:	:	PUNCT
dpc-5139	4	26	a	a	DET
dpc-5139	4	27	case	case	NOUN
dpc-5139	4	28	study	study	NOUN
dpc-5139	4	29	and	and	CCONJ
dpc-5139	4	30	therapeutic	therapeutic	ADJ
dpc-5139	4	31	insight	insight	NOUN
dpc-5139	4	32	.	.	PUNCT
dpc-5139	5	1	dermatol	dermatol	NOUN
dpc-5139	5	2	pract	pract	PROPN
dpc-5139	5	3	concept	concept	NOUN
dpc-5139	5	4	.	.	PUNCT
dpc-5139	6	1	2025;15(2):5139	2025;15(2):5139	NUM
dpc-5139	6	2	.	.	PUNCT
dpc-5139	7	1	doi	doi	NOUN
dpc-5139	7	2	:	:	PUNCT
dpc-5139	7	3	https://doi.org/10.5826/	https://doi.org/10.5826/	PROPN
dpc-5139	7	4	dpc.1502a5139	dpc.1502a5139	NOUN
dpc-5139	7	5	accepted	accept	VERB
dpc-5139	7	6	:	:	PUNCT
dpc-5139	7	7	december	december	PROPN
dpc-5139	7	8	2	2	NUM
dpc-5139	7	9	,	,	PUNCT
dpc-5139	7	10	2024	2024	NUM
dpc-5139	7	11	;	;	PUNCT
dpc-5139	7	12	published	publish	VERB
dpc-5139	7	13	:	:	PUNCT
dpc-5139	8	1	april	april	PROPN
dpc-5139	8	2	2025	2025	NUM
dpc-5139	8	3	copyright	copyright	NOUN
dpc-5139	8	4	:	:	PUNCT
dpc-5139	8	5	©	©	PROPN
dpc-5139	8	6	2025	2025	NUM
dpc-5139	8	7	falcinelli	falcinelli	NOUN
dpc-5139	8	8	et	et	PROPN
dpc-5139	8	9	al	al	PROPN
dpc-5139	8	10	.	.	PUNCT
dpc-5139	9	1	this	this	PRON
dpc-5139	9	2	is	be	AUX
dpc-5139	9	3	an	an	DET
dpc-5139	9	4	open	open	ADJ
dpc-5139	9	5	-	-	PUNCT
dpc-5139	9	6	access	access	NOUN
dpc-5139	9	7	article	article	NOUN
dpc-5139	9	8	distributed	distribute	VERB
dpc-5139	9	9	under	under	ADP
dpc-5139	9	10	the	the	DET
dpc-5139	9	11	terms	term	NOUN
dpc-5139	9	12	of	of	ADP
dpc-5139	9	13	the	the	DET
dpc-5139	9	14	creative	creative	ADJ
dpc-5139	9	15	commons	common	NOUN
dpc-5139	9	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-5139	9	17	license	license	NOUN
dpc-5139	9	18	(	(	PUNCT
dpc-5139	9	19	by	by	ADP
dpc-5139	9	20	-	-	PUNCT
dpc-5139	9	21	nc-4.0	nc-4.0	NOUN
dpc-5139	9	22	)	)	PUNCT
dpc-5139	9	23	,	,	PUNCT
dpc-5139	9	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-5139	9	25	,	,	PUNCT
dpc-5139	9	26	which	which	PRON
dpc-5139	9	27	permits	permit	VERB
dpc-5139	9	28	unrestricted	unrestricted	ADJ
dpc-5139	9	29	noncommercial	noncommercial	ADJ
dpc-5139	9	30	use	use	NOUN
dpc-5139	9	31	,	,	PUNCT
dpc-5139	9	32	distribution	distribution	NOUN
dpc-5139	9	33	,	,	PUNCT
dpc-5139	9	34	and	and	CCONJ
dpc-5139	9	35	reproduction	reproduction	NOUN
dpc-5139	9	36	in	in	ADP
dpc-5139	9	37	any	any	DET
dpc-5139	9	38	medium	medium	NOUN
dpc-5139	9	39	,	,	PUNCT
dpc-5139	9	40	provided	provide	VERB
dpc-5139	9	41	the	the	DET
dpc-5139	9	42	original	original	ADJ
dpc-5139	9	43	authors	author	NOUN
dpc-5139	9	44	and	and	CCONJ
dpc-5139	9	45	source	source	NOUN
dpc-5139	9	46	are	be	AUX
dpc-5139	9	47	credited	credit	VERB
dpc-5139	9	48	.	.	PUNCT
dpc-5139	10	1	funding	funding	NOUN
dpc-5139	10	2	:	:	PUNCT
dpc-5139	10	3	none	none	NOUN
dpc-5139	10	4	.	.	PUNCT
dpc-5139	11	1	competing	compete	VERB
dpc-5139	11	2	interests	interest	NOUN
dpc-5139	11	3	:	:	PUNCT
dpc-5139	11	4	none	none	NOUN
dpc-5139	11	5	.	.	PUNCT
dpc-5139	12	1	authorship	authorship	NOUN
dpc-5139	12	2	:	:	PUNCT
dpc-5139	12	3	all	all	DET
dpc-5139	12	4	authors	author	NOUN
dpc-5139	12	5	read	read	VERB
dpc-5139	12	6	and	and	CCONJ
dpc-5139	12	7	approved	approve	VERB
dpc-5139	12	8	the	the	DET
dpc-5139	12	9	final	final	ADJ
dpc-5139	12	10	version	version	NOUN
dpc-5139	12	11	of	of	ADP
dpc-5139	12	12	the	the	DET
dpc-5139	12	13	article	article	NOUN
dpc-5139	12	14	.	.	PUNCT
dpc-5139	13	1	f.f	f.f	PROPN
dpc-5139	13	2	.	.	PROPN
dpc-5139	13	3	contributed	contribute	VERB
dpc-5139	13	4	to	to	PART
dpc-5139	13	5	design	design	VERB
dpc-5139	13	6	,	,	PUNCT
dpc-5139	13	7	writing	writing	NOUN
dpc-5139	13	8	,	,	PUNCT
dpc-5139	13	9	editing	editing	NOUN
dpc-5139	13	10	.	.	PUNCT
dpc-5139	14	1	e.c	e.c	PROPN
dpc-5139	14	2	.	.	PROPN
dpc-5139	14	3	carried	carry	VERB
dpc-5139	14	4	out	out	ADP
dpc-5139	14	5	data	datum	NOUN
dpc-5139	14	6	collection	collection	NOUN
dpc-5139	14	7	,	,	PUNCT
dpc-5139	14	8	therapy	therapy	NOUN
dpc-5139	14	9	,	,	PUNCT
dpc-5139	14	10	and	and	CCONJ
dpc-5139	14	11	review	review	NOUN
dpc-5139	14	12	.	.	PUNCT
dpc-5139	15	1	l.c	l.c	AUX
dpc-5139	15	2	.	.	PROPN
dpc-5139	15	3	contributed	contribute	VERB
dpc-5139	15	4	to	to	PART
dpc-5139	15	5	design	design	VERB
dpc-5139	15	6	,	,	PUNCT
dpc-5139	15	7	writing	writing	NOUN
dpc-5139	15	8	,	,	PUNCT
dpc-5139	15	9	therapy	therapy	NOUN
dpc-5139	15	10	,	,	PUNCT
dpc-5139	15	11	and	and	CCONJ
dpc-5139	15	12	review	review	NOUN
dpc-5139	15	13	.	.	PUNCT
dpc-5139	16	1	p.r	p.r	PROPN
dpc-5139	16	2	.	.	PROPN
dpc-5139	16	3	,	,	PUNCT
dpc-5139	16	4	b.f	b.f	PROPN
dpc-5139	16	5	.	.	PROPN
dpc-5139	16	6	,	,	PUNCT
dpc-5139	16	7	l.c	l.c	PROPN
dpc-5139	16	8	.	.	PROPN
dpc-5139	16	9	carried	carry	VERB
dpc-5139	16	10	out	out	ADP
dpc-5139	16	11	review	review	NOUN
dpc-5139	16	12	.	.	PUNCT
dpc-5139	17	1	corresponding	correspond	VERB
dpc-5139	17	2	author	author	NOUN
dpc-5139	17	3	:	:	PUNCT
dpc-5139	17	4	francesca	francesca	PROPN
dpc-5139	17	5	falcinelli	falcinelli	PROPN
dpc-5139	17	6	,	,	PUNCT
dpc-5139	17	7	md	md	PROPN
dpc-5139	17	8	;	;	PUNCT
dpc-5139	17	9	department	department	NOUN
dpc-5139	17	10	of	of	ADP
dpc-5139	17	11	dermatology	dermatology	NOUN
dpc-5139	17	12	division	division	NOUN
dpc-5139	17	13	of	of	ADP
dpc-5139	17	14	medical	medical	ADJ
dpc-5139	17	15	,	,	PUNCT
dpc-5139	17	16	surgical	surgical	ADJ
dpc-5139	17	17	and	and	CCONJ
dpc-5139	17	18	neurosciences	neuroscience	NOUN
dpc-5139	17	19	,	,	PUNCT
dpc-5139	17	20	university	university	NOUN
dpc-5139	17	21	of	of	ADP
dpc-5139	17	22	siena	siena	PROPN
dpc-5139	17	23	le	le	PROPN
dpc-5139	17	24	scotte	scotte	PROPN
dpc-5139	17	25	hospital	hospital	NOUN
dpc-5139	17	26	,	,	PUNCT
dpc-5139	17	27	viale	viale	PROPN
dpc-5139	17	28	bracci	bracci	NOUN
dpc-5139	17	29	16	16	NUM
dpc-5139	17	30	,	,	PUNCT
dpc-5139	17	31	53100	53100	NUM
dpc-5139	17	32	siena	siena	PROPN
dpc-5139	17	33	(	(	PUNCT
dpc-5139	17	34	italy	italy	PROPN
dpc-5139	17	35	)	)	PUNCT
dpc-5139	17	36	;	;	PUNCT
dpc-5139	17	37	orcid	orcid	PROPN
dpc-5139	18	1	i	i	PRON
dpc-5139	18	2	d	d	NOUN
dpc-5139	18	3	:	:	PUNCT
dpc-5139	18	4	0000	0000	NUM
dpc-5139	18	5	-	-	PUNCT
dpc-5139	18	6	0002	0002	NUM
dpc-5139	18	7	-	-	PUNCT
dpc-5139	18	8	3149	3149	NUM
dpc-5139	18	9	-	-	SYM
dpc-5139	18	10	8695	8695	NUM
dpc-5139	18	11	e	e	NOUN
dpc-5139	18	12	-	-	NOUN
dpc-5139	18	13	mail	mail	NOUN
dpc-5139	18	14	:	:	PUNCT
dpc-5139	18	15	f.falcinelli@student	f.falcinelli@student	NOUN
dpc-5139	18	16	.	.	PUNCT
dpc-5139	19	1	unisi.it	unisi.it	DET
dpc-5139	19	2	informed	informed	ADJ
dpc-5139	19	3	consent	consent	NOUN
dpc-5139	19	4	:	:	PUNCT
dpc-5139	19	5	the	the	DET
dpc-5139	19	6	patient	patient	NOUN
dpc-5139	19	7	in	in	ADP
dpc-5139	19	8	this	this	DET
dpc-5139	19	9	manuscript	manuscript	NOUN
dpc-5139	19	10	has	have	AUX
dpc-5139	19	11	given	give	VERB
dpc-5139	19	12	written	write	VERB
dpc-5139	19	13	informed	inform	VERB
dpc-5139	19	14	consent	consent	NOUN
dpc-5139	19	15	to	to	ADP
dpc-5139	19	16	the	the	DET
dpc-5139	19	17	publication	publication	NOUN
dpc-5139	19	18	of	of	ADP
dpc-5139	19	19	her	her	PRON
dpc-5139	19	20	case	case	NOUN
dpc-5139	19	21	details	detail	NOUN
dpc-5139	19	22	.	.	PUNCT
dpc-5139	20	1	key	key	ADJ
dpc-5139	20	2	words	word	NOUN
dpc-5139	20	3	:	:	PUNCT
dpc-5139	20	4	urticarial	urticarial	ADJ
dpc-5139	20	5	vasculitis	vasculitis	PROPN
dpc-5139	20	6	,	,	PUNCT
dpc-5139	20	7	leukocytoclastic	leukocytoclastic	ADJ
dpc-5139	20	8	vasculitis	vasculitis	PROPN
dpc-5139	20	9	,	,	PUNCT
dpc-5139	20	10	upadacitinib	upadacitinib	NOUN
dpc-5139	20	11	,	,	PUNCT
dpc-5139	20	12	jak	jak	PROPN
dpc-5139	20	13	inhibitors	inhibitor	NOUN
dpc-5139	20	14	,	,	PUNCT
dpc-5139	20	15	janus	janus	PROPN
dpc-5139	20	16	kinase	kinase	PROPN
dpc-5139	20	17	inhibitors	inhibitor	NOUN
dpc-5139	20	18	introduction	introduction	NOUN
dpc-5139	20	19	urticarial	urticarial	ADJ
dpc-5139	20	20	vasculitis	vasculitis	NOUN
dpc-5139	20	21	(	(	PUNCT
dpc-5139	20	22	uv	uv	NOUN
dpc-5139	20	23	)	)	PUNCT
dpc-5139	20	24	is	be	AUX
dpc-5139	20	25	a	a	DET
dpc-5139	20	26	rare	rare	ADJ
dpc-5139	20	27	entity	entity	NOUN
dpc-5139	20	28	characterized	characterize	VERB
dpc-5139	20	29	by	by	ADP
dpc-5139	20	30	recurrent	recurrent	ADJ
dpc-5139	20	31	episodes	episode	NOUN
dpc-5139	20	32	of	of	ADP
dpc-5139	20	33	wheal	wheal	ADJ
dpc-5139	20	34	-	-	PUNCT
dpc-5139	20	35	like	like	ADJ
dpc-5139	20	36	lesions	lesion	NOUN
dpc-5139	20	37	and	and	CCONJ
dpc-5139	20	38	evidence	evidence	NOUN
dpc-5139	20	39	of	of	ADP
dpc-5139	20	40	leukocytoclastic	leukocytoclastic	ADJ
dpc-5139	20	41	vasculitis	vasculitis	PROPN
dpc-5139	20	42	on	on	ADP
dpc-5139	20	43	skin	skin	NOUN
dpc-5139	20	44	biopsy	biopsy	NOUN
dpc-5139	20	45	.	.	PUNCT
dpc-5139	21	1	although	although	SCONJ
dpc-5139	21	2	its	its	PRON
dpc-5139	21	3	etiopathogenesis	etiopathogenesis	NOUN
dpc-5139	21	4	remains	remain	VERB
dpc-5139	21	5	undefined	undefined	ADJ
dpc-5139	21	6	,	,	PUNCT
dpc-5139	21	7	it	it	PRON
dpc-5139	21	8	seems	seem	VERB
dpc-5139	21	9	to	to	PART
dpc-5139	21	10	be	be	AUX
dpc-5139	21	11	driven	drive	VERB
dpc-5139	21	12	by	by	ADP
dpc-5139	21	13	a	a	DET
dpc-5139	21	14	type	type	NOUN
dpc-5139	21	15	iii	iii	NUM
dpc-5139	21	16	immune	immune	ADJ
dpc-5139	21	17	reaction	reaction	NOUN
dpc-5139	21	18	,	,	PUNCT
dpc-5139	21	19	and	and	CCONJ
dpc-5139	21	20	its	its	PRON
dpc-5139	21	21	treatment	treatment	NOUN
dpc-5139	21	22	is	be	AUX
dpc-5139	21	23	often	often	ADV
dpc-5139	21	24	challenging	challenge	VERB
dpc-5139	21	25	[	[	X
dpc-5139	21	26	1	1	NUM
dpc-5139	21	27	]	]	PUNCT
dpc-5139	21	28	.	.	PUNCT
dpc-5139	22	1	case	case	NOUN
dpc-5139	22	2	presentation	presentation	NOUN
dpc-5139	22	3	a	a	DET
dpc-5139	22	4	77	77	NUM
dpc-5139	22	5	-	-	PUNCT
dpc-5139	22	6	year	year	NOUN
dpc-5139	22	7	-	-	PUNCT
dpc-5139	22	8	old	old	ADJ
dpc-5139	22	9	woman	woman	NOUN
dpc-5139	22	10	presented	present	VERB
dpc-5139	22	11	for	for	ADP
dpc-5139	22	12	itchy	itchy	ADJ
dpc-5139	22	13	urticarial	urticarial	ADJ
dpc-5139	22	14	lesions	lesion	NOUN
dpc-5139	22	15	,	,	PUNCT
dpc-5139	22	16	widespread	widespread	ADJ
dpc-5139	22	17	on	on	ADP
dpc-5139	22	18	the	the	DET
dpc-5139	22	19	limbs	limb	NOUN
dpc-5139	22	20	and	and	CCONJ
dpc-5139	22	21	trunk	trunk	NOUN
dpc-5139	22	22	,	,	PUNCT
dpc-5139	22	23	that	that	PRON
dpc-5139	22	24	had	have	AUX
dpc-5139	22	25	been	be	AUX
dpc-5139	22	26	present	present	ADJ
dpc-5139	22	27	for	for	ADP
dpc-5139	22	28	about	about	ADV
dpc-5139	22	29	15	15	NUM
dpc-5139	22	30	years	year	NOUN
dpc-5139	22	31	with	with	ADP
dpc-5139	22	32	a	a	DET
dpc-5139	22	33	chronic	chronic	ADJ
dpc-5139	22	34	relapsing	relapse	VERB
dpc-5139	22	35	course	course	NOUN
dpc-5139	22	36	.	.	PUNCT
dpc-5139	23	1	she	she	PRON
dpc-5139	23	2	had	have	VERB
dpc-5139	23	3	a	a	DET
dpc-5139	23	4	history	history	NOUN
dpc-5139	23	5	of	of	ADP
dpc-5139	23	6	chronic	chronic	ADJ
dpc-5139	23	7	urticaria	urticaria	NOUN
dpc-5139	23	8	,	,	PUNCT
dpc-5139	23	9	psoriatic	psoriatic	ADJ
dpc-5139	23	10	arthritis	arthritis	NOUN
dpc-5139	23	11	,	,	PUNCT
dpc-5139	23	12	and	and	CCONJ
dpc-5139	23	13	mild	mild	ADJ
dpc-5139	23	14	psoriasis	psoriasis	NOUN
dpc-5139	23	15	vulgaris	vulgaris	NOUN
dpc-5139	23	16	that	that	PRON
dpc-5139	23	17	had	have	AUX
dpc-5139	23	18	been	be	AUX
dpc-5139	23	19	effectively	effectively	ADV
dpc-5139	23	20	treated	treat	VERB
dpc-5139	23	21	over	over	ADP
dpc-5139	23	22	the	the	DET
dpc-5139	23	23	years	year	NOUN
dpc-5139	23	24	with	with	ADP
dpc-5139	23	25	corticosteroids	corticosteroid	NOUN
dpc-5139	23	26	,	,	PUNCT
dpc-5139	23	27	antihistamines	antihistamine	NOUN
dpc-5139	23	28	,	,	PUNCT
dpc-5139	23	29	and	and	CCONJ
dpc-5139	23	30	cyclosporin	cyclosporin	NOUN
dpc-5139	23	31	,	,	PUNCT
dpc-5139	23	32	which	which	PRON
dpc-5139	23	33	was	be	AUX
dpc-5139	23	34	gradually	gradually	ADV
dpc-5139	23	35	tapered	taper	VERB
dpc-5139	23	36	due	due	ADP
dpc-5139	23	37	to	to	ADP
dpc-5139	23	38	prolonged	prolonged	ADJ
dpc-5139	23	39	remission	remission	NOUN
dpc-5139	23	40	.	.	PUNCT
dpc-5139	24	1	after	after	ADP
dpc-5139	24	2	a	a	DET
dpc-5139	24	3	sarscov-2	sarscov-2	NUM
dpc-5139	24	4	infection	infection	NOUN
dpc-5139	24	5	,	,	PUNCT
dpc-5139	24	6	the	the	DET
dpc-5139	24	7	patient	patient	NOUN
dpc-5139	24	8	reported	report	VERB
dpc-5139	24	9	a	a	DET
dpc-5139	24	10	flare	flare	NOUN
dpc-5139	24	11	of	of	ADP
dpc-5139	24	12	oligoarthritis	oligoarthritis	NOUN
dpc-5139	25	1	[	[	X
dpc-5139	25	2	disease	disease	NOUN
dpc-5139	25	3	activity	activity	NOUN
dpc-5139	25	4	in	in	ADP
dpc-5139	25	5	psoriatic	psoriatic	ADJ
dpc-5139	25	6	arthitis	arthitis	NOUN
dpc-5139	25	7	(	(	PUNCT
dpc-5139	25	8	dapsa	dapsa	PROPN
dpc-5139	25	9	)	)	PUNCT
dpc-5139	25	10	28	28	NUM
dpc-5139	25	11	]	]	PUNCT
dpc-5139	25	12	,	,	PUNCT
dpc-5139	25	13	which	which	PRON
dpc-5139	25	14	was	be	AUX
dpc-5139	25	15	treated	treat	VERB
dpc-5139	25	16	with	with	ADP
dpc-5139	25	17	methotrexate	methotrexate	NOUN
dpc-5139	25	18	,	,	PUNCT
dpc-5139	25	19	then	then	ADV
dpc-5139	25	20	discontinued	discontinue	VERB
dpc-5139	25	21	due	due	ADP
dpc-5139	25	22	to	to	ADP
dpc-5139	25	23	gastrointestinal	gastrointestinal	ADJ
dpc-5139	25	24	intolerance	intolerance	NOUN
dpc-5139	25	25	,	,	PUNCT
dpc-5139	25	26	and	and	CCONJ
dpc-5139	25	27	subsequently	subsequently	ADV
dpc-5139	25	28	with	with	ADP
dpc-5139	25	29	adalimumab	adalimumab	NOUN
dpc-5139	25	30	40	40	NUM
dpc-5139	25	31	mg	mg	NOUN
dpc-5139	25	32	every	every	DET
dpc-5139	25	33	other	other	ADJ
dpc-5139	25	34	week	week	NOUN
dpc-5139	25	35	.	.	PUNCT
dpc-5139	26	1	after	after	ADP
dpc-5139	26	2	three	three	NUM
dpc-5139	26	3	months	month	NOUN
dpc-5139	26	4	of	of	ADP
dpc-5139	26	5	treatment	treatment	NOUN
dpc-5139	26	6	with	with	ADP
dpc-5139	26	7	adalimumab	adalimumab	NOUN
dpc-5139	26	8	,	,	PUNCT
dpc-5139	26	9	a	a	DET
dpc-5139	26	10	partial	partial	ADJ
dpc-5139	26	11	improvement	improvement	NOUN
dpc-5139	26	12	in	in	ADP
dpc-5139	26	13	arthritis	arthritis	NOUN
dpc-5139	26	14	was	be	AUX
dpc-5139	26	15	observed	observe	VERB
dpc-5139	26	16	(	(	PUNCT
dpc-5139	26	17	dapsa	dapsa	NOUN
dpc-5139	26	18	18	18	NUM
dpc-5139	26	19	)	)	PUNCT
dpc-5139	26	20	,	,	PUNCT
dpc-5139	26	21	despite	despite	SCONJ
dpc-5139	26	22	a	a	DET
dpc-5139	26	23	severe	severe	ADJ
dpc-5139	26	24	worsening	worsening	NOUN
dpc-5139	26	25	of	of	ADP
dpc-5139	26	26	urticarial	urticarial	ADJ
dpc-5139	26	27	skin	skin	NOUN
dpc-5139	26	28	lesions	lesion	NOUN
dpc-5139	26	29	,	,	PUNCT
dpc-5139	26	30	whereby	whereby	SCONJ
dpc-5139	26	31	the	the	DET
dpc-5139	26	32	patient	patient	NOUN
dpc-5139	26	33	came	come	VERB
dpc-5139	26	34	to	to	ADP
dpc-5139	26	35	our	our	PRON
dpc-5139	26	36	attention	attention	NOUN
dpc-5139	26	37	.	.	PUNCT
dpc-5139	27	1	on	on	ADP
dpc-5139	27	2	skin	skin	NOUN
dpc-5139	27	3	examination	examination	NOUN
dpc-5139	27	4	,	,	PUNCT
dpc-5139	27	5	diffuse	diffuse	PROPN
dpc-5139	27	6	pinkish	pinkish	NOUN
dpc-5139	27	7	and	and	CCONJ
dpc-5139	27	8	orange	orange	ADJ
dpc-5139	27	9	colored	colored	ADJ
dpc-5139	27	10	wheals	wheal	NOUN
dpc-5139	27	11	were	be	AUX
dpc-5139	27	12	present	present	ADJ
dpc-5139	27	13	on	on	ADP
dpc-5139	27	14	the	the	DET
dpc-5139	27	15	limbs	limb	NOUN
dpc-5139	27	16	and	and	CCONJ
dpc-5139	27	17	trunk	trunk	NOUN
dpc-5139	27	18	,	,	PUNCT
dpc-5139	27	19	associated	associate	VERB
dpc-5139	27	20	with	with	ADP
dpc-5139	27	21	ecchymotic	ecchymotic	ADJ
dpc-5139	27	22	hyperpigmentation	hyperpigmentation	NOUN
dpc-5139	27	23	(	(	PUNCT
dpc-5139	27	24	figure	figure	NOUN
dpc-5139	27	25	1a	1a	NOUN
dpc-5139	27	26	–	–	PUNCT
dpc-5139	27	27	c	c	NOUN
dpc-5139	27	28	)	)	PUNCT
dpc-5139	27	29	.	.	PUNCT
dpc-5139	28	1	no	no	DET
dpc-5139	28	2	sign	sign	NOUN
dpc-5139	28	3	of	of	ADP
dpc-5139	28	4	psoriasis	psoriasis	NOUN
dpc-5139	28	5	was	be	AUX
dpc-5139	28	6	present	present	ADJ
dpc-5139	28	7	[	[	X
dpc-5139	28	8	psoriasis	psoriasis	NOUN
dpc-5139	28	9	area	area	NOUN
dpc-5139	28	10	and	and	CCONJ
dpc-5139	28	11	severity	severity	NOUN
dpc-5139	28	12	2	2	NUM
dpc-5139	28	13	research	research	NOUN
dpc-5139	28	14	letter	letter	NOUN
dpc-5139	29	1	|	|	ADV
dpc-5139	29	2	dermatol	dermatol	ADJ
dpc-5139	29	3	pract	pract	NOUN
dpc-5139	29	4	concept	concept	NOUN
dpc-5139	29	5	.	.	PUNCT
dpc-5139	30	1	2025;15(2):5139	2025;15(2):5139	NUM
dpc-5139	30	2	index	index	NOUN
dpc-5139	30	3	(	(	PUNCT
dpc-5139	30	4	pasi	pasi	NOUN
dpc-5139	30	5	)	)	PUNCT
dpc-5139	30	6	0	0	NUM
dpc-5139	30	7	]	]	PUNCT
dpc-5139	30	8	.	.	PUNCT
dpc-5139	31	1	upon	upon	SCONJ
dpc-5139	31	2	considering	consider	VERB
dpc-5139	31	3	the	the	DET
dpc-5139	31	4	persistence	persistence	NOUN
dpc-5139	31	5	of	of	ADP
dpc-5139	31	6	the	the	DET
dpc-5139	31	7	lesions	lesion	NOUN
dpc-5139	31	8	present	present	VERB
dpc-5139	31	9	longer	long	ADV
dpc-5139	31	10	than	than	ADP
dpc-5139	31	11	24	24	NUM
dpc-5139	31	12	hours	hour	NOUN
dpc-5139	31	13	,	,	PUNCT
dpc-5139	31	14	their	their	PRON
dpc-5139	31	15	color	color	NOUN
dpc-5139	31	16	,	,	PUNCT
dpc-5139	31	17	and	and	CCONJ
dpc-5139	31	18	failure	failure	NOUN
dpc-5139	31	19	to	to	PART
dpc-5139	31	20	disappear	disappear	VERB
dpc-5139	31	21	upon	upon	SCONJ
dpc-5139	31	22	pressure	pressure	NOUN
dpc-5139	31	23	,	,	PUNCT
dpc-5139	31	24	urticarial	urticarial	ADJ
dpc-5139	31	25	vasculitis	vasculitis	PROPN
dpc-5139	31	26	was	be	AUX
dpc-5139	31	27	suspected	suspect	VERB
dpc-5139	31	28	,	,	PUNCT
dpc-5139	31	29	and	and	CCONJ
dpc-5139	31	30	a	a	DET
dpc-5139	31	31	biopsy	biopsy	NOUN
dpc-5139	31	32	was	be	AUX
dpc-5139	31	33	performed	perform	VERB
dpc-5139	31	34	,	,	PUNCT
dpc-5139	31	35	showing	show	VERB
dpc-5139	31	36	leukocytoclastic	leukocytoclastic	ADJ
dpc-5139	31	37	vasculitis	vasculitis	NOUN
dpc-5139	31	38	.	.	PUNCT
dpc-5139	32	1	blood	blood	NOUN
dpc-5139	32	2	examinations	examination	NOUN
dpc-5139	32	3	revealed	reveal	VERB
dpc-5139	32	4	increased	increase	VERB
dpc-5139	32	5	c	c	NOUN
dpc-5139	32	6	-	-	PUNCT
dpc-5139	32	7	reactive	reactive	ADJ
dpc-5139	32	8	protein	protein	NOUN
dpc-5139	32	9	,	,	PUNCT
dpc-5139	32	10	normal	normal	ADJ
dpc-5139	32	11	c1q	c1q	NOUN
dpc-5139	32	12	and	and	CCONJ
dpc-5139	32	13	complement	complement	NOUN
dpc-5139	32	14	levels	level	NOUN
dpc-5139	32	15	as	as	ADV
dpc-5139	32	16	well	well	ADV
dpc-5139	32	17	as	as	ADP
dpc-5139	32	18	negative	negative	ADJ
dpc-5139	32	19	autoimmunity	autoimmunity	NOUN
dpc-5139	32	20	antibodies	antibodie	VERB
dpc-5139	32	21	screening	screening	NOUN
dpc-5139	32	22	.	.	PUNCT
dpc-5139	33	1	based	base	VERB
dpc-5139	33	2	on	on	ADP
dpc-5139	33	3	clinical	clinical	ADJ
dpc-5139	33	4	and	and	CCONJ
dpc-5139	33	5	histopathologic	histopathologic	ADJ
dpc-5139	33	6	data	datum	NOUN
dpc-5139	33	7	,	,	PUNCT
dpc-5139	33	8	a	a	DET
dpc-5139	33	9	diagnosis	diagnosis	NOUN
dpc-5139	33	10	of	of	ADP
dpc-5139	33	11	uv	uv	NOUN
dpc-5139	33	12	was	be	AUX
dpc-5139	33	13	made	make	VERB
dpc-5139	33	14	.	.	PUNCT
dpc-5139	34	1	therapy	therapy	NOUN
dpc-5139	34	2	with	with	ADP
dpc-5139	34	3	adalimumab	adalimumab	NOUN
dpc-5139	34	4	was	be	AUX
dpc-5139	34	5	suspended	suspend	VERB
dpc-5139	34	6	and	and	CCONJ
dpc-5139	34	7	upadacitinib	upadacitinib	NOUN
dpc-5139	34	8	15	15	NUM
dpc-5139	34	9	mg	mg	NOUN
dpc-5139	34	10	daily	daily	ADV
dpc-5139	34	11	was	be	AUX
dpc-5139	34	12	started	start	VERB
dpc-5139	34	13	.	.	PUNCT
dpc-5139	35	1	after	after	ADP
dpc-5139	35	2	one	one	NUM
dpc-5139	35	3	month	month	NOUN
dpc-5139	35	4	,	,	PUNCT
dpc-5139	35	5	the	the	DET
dpc-5139	35	6	patient	patient	NOUN
dpc-5139	35	7	reported	report	VERB
dpc-5139	35	8	partial	partial	ADJ
dpc-5139	35	9	improvement	improvement	NOUN
dpc-5139	35	10	of	of	ADP
dpc-5139	35	11	cutaneous	cutaneous	ADJ
dpc-5139	35	12	and	and	CCONJ
dpc-5139	35	13	articular	articular	ADJ
dpc-5139	35	14	symptoms	symptom	NOUN
dpc-5139	35	15	,	,	PUNCT
dpc-5139	35	16	with	with	ADP
dpc-5139	35	17	clear	clear	ADJ
dpc-5139	35	18	worsening	worsen	VERB
dpc-5139	35	19	eight	eight	NUM
dpc-5139	35	20	hours	hour	NOUN
dpc-5139	35	21	after	after	ADP
dpc-5139	35	22	taking	take	VERB
dpc-5139	35	23	medication	medication	NOUN
dpc-5139	35	24	.	.	PUNCT
dpc-5139	36	1	therefore	therefore	ADV
dpc-5139	36	2	,	,	PUNCT
dpc-5139	36	3	we	we	PRON
dpc-5139	36	4	decided	decide	VERB
dpc-5139	36	5	to	to	PART
dpc-5139	36	6	increase	increase	VERB
dpc-5139	36	7	the	the	DET
dpc-5139	36	8	dosage	dosage	NOUN
dpc-5139	36	9	of	of	ADP
dpc-5139	36	10	upadacitinib	upadacitinib	NOUN
dpc-5139	36	11	to	to	ADP
dpc-5139	36	12	15	15	NUM
dpc-5139	36	13	mg	mg	NOUN
dpc-5139	36	14	twice	twice	DET
dpc-5139	36	15	a	a	DET
dpc-5139	36	16	day	day	NOUN
dpc-5139	36	17	,	,	PUNCT
dpc-5139	36	18	resulting	result	VERB
dpc-5139	36	19	in	in	ADP
dpc-5139	36	20	complete	complete	ADJ
dpc-5139	36	21	remission	remission	NOUN
dpc-5139	36	22	of	of	ADP
dpc-5139	36	23	urticarial	urticarial	ADJ
dpc-5139	36	24	lesions	lesion	NOUN
dpc-5139	36	25	and	and	CCONJ
dpc-5139	36	26	significant	significant	ADJ
dpc-5139	36	27	improvement	improvement	NOUN
dpc-5139	36	28	in	in	ADP
dpc-5139	36	29	artrithis	artrithis	PROPN
dpc-5139	36	30	(	(	PUNCT
dpc-5139	36	31	dapsa	dapsa	NOUN
dpc-5139	36	32	5	5	NUM
dpc-5139	36	33	)	)	PUNCT
dpc-5139	36	34	,	,	PUNCT
dpc-5139	36	35	at	at	ADP
dpc-5139	36	36	follow	follow	NOUN
dpc-5139	36	37	-	-	PUNCT
dpc-5139	36	38	up	up	NOUN
dpc-5139	36	39	after	after	ADP
dpc-5139	36	40	three	three	NUM
dpc-5139	36	41	months	month	NOUN
dpc-5139	36	42	(	(	PUNCT
dpc-5139	36	43	figure	figure	NOUN
dpc-5139	36	44	1d	1d	NUM
dpc-5139	36	45	–	–	PUNCT
dpc-5139	36	46	f	f	NOUN
dpc-5139	36	47	)	)	PUNCT
dpc-5139	36	48	.	.	PUNCT
dpc-5139	37	1	conclusion	conclusion	NOUN
dpc-5139	37	2	upadacitinib	upadacitinib	NOUN
dpc-5139	37	3	is	be	AUX
dpc-5139	37	4	a	a	DET
dpc-5139	37	5	selective	selective	ADJ
dpc-5139	37	6	jak-1	jak-1	PUNCT
dpc-5139	37	7	inhibitor	inhibitor	NOUN
dpc-5139	37	8	recently	recently	ADV
dpc-5139	37	9	approved	approve	VERB
dpc-5139	37	10	for	for	ADP
dpc-5139	37	11	the	the	DET
dpc-5139	37	12	treatment	treatment	NOUN
dpc-5139	37	13	of	of	ADP
dpc-5139	37	14	psoriatic	psoriatic	ADJ
dpc-5139	37	15	arthritis	arthritis	NOUN
dpc-5139	37	16	and	and	CCONJ
dpc-5139	37	17	atopic	atopic	NOUN
dpc-5139	37	18	dermatitis	dermatitis	NOUN
dpc-5139	37	19	.	.	PUNCT
dpc-5139	38	1	nevertheless	nevertheless	ADV
dpc-5139	38	2	,	,	PUNCT
dpc-5139	38	3	the	the	DET
dpc-5139	38	4	drug	drug	NOUN
dpc-5139	38	5	targets	target	VERB
dpc-5139	38	6	multiple	multiple	ADJ
dpc-5139	38	7	inflammatory	inflammatory	ADJ
dpc-5139	38	8	cytokines	cytokine	NOUN
dpc-5139	38	9	involved	involve	VERB
dpc-5139	38	10	in	in	ADP
dpc-5139	38	11	the	the	DET
dpc-5139	38	12	pathogenesis	pathogenesis	NOUN
dpc-5139	38	13	of	of	ADP
dpc-5139	38	14	various	various	ADJ
dpc-5139	38	15	inflammatory	inflammatory	ADJ
dpc-5139	38	16	diseases	disease	NOUN
dpc-5139	38	17	[	[	X
dpc-5139	38	18	2	2	NUM
dpc-5139	38	19	]	]	PUNCT
dpc-5139	38	20	.	.	PUNCT
dpc-5139	39	1	with	with	ADP
dpc-5139	39	2	regard	regard	NOUN
dpc-5139	39	3	to	to	ADP
dpc-5139	39	4	jaki	jaki	PROPN
dpc-5139	39	5	,	,	PUNCT
dpc-5139	39	6	the	the	DET
dpc-5139	39	7	literature	literature	NOUN
dpc-5139	39	8	reports	report	VERB
dpc-5139	39	9	a	a	DET
dpc-5139	39	10	successful	successful	ADJ
dpc-5139	39	11	use	use	NOUN
dpc-5139	39	12	of	of	ADP
dpc-5139	39	13	the	the	DET
dpc-5139	39	14	pan	pan	PROPN
dpc-5139	39	15	-	-	PROPN
dpc-5139	39	16	jaki	jaki	PROPN
dpc-5139	39	17	tofacitinib	tofacitinib	PROPN
dpc-5139	39	18	in	in	ADP
dpc-5139	39	19	one	one	NUM
dpc-5139	39	20	case	case	NOUN
dpc-5139	39	21	of	of	ADP
dpc-5139	39	22	uv	uv	NOUN
dpc-5139	39	23	[	[	X
dpc-5139	39	24	3	3	NUM
dpc-5139	39	25	]	]	PUNCT
dpc-5139	39	26	and	and	CCONJ
dpc-5139	39	27	in	in	ADP
dpc-5139	39	28	one	one	NUM
dpc-5139	39	29	case	case	NOUN
dpc-5139	39	30	of	of	ADP
dpc-5139	39	31	leukocytoclastic	leukocytoclastic	ADJ
dpc-5139	39	32	vasculitis	vasculitis	PROPN
dpc-5139	39	33	[	[	X
dpc-5139	39	34	4	4	NUM
dpc-5139	39	35	]	]	PUNCT
dpc-5139	39	36	.	.	PUNCT
dpc-5139	40	1	however	however	ADV
dpc-5139	40	2	,	,	PUNCT
dpc-5139	40	3	evidence	evidence	NOUN
dpc-5139	40	4	of	of	ADP
dpc-5139	40	5	the	the	DET
dpc-5139	40	6	role	role	NOUN
dpc-5139	40	7	of	of	ADP
dpc-5139	40	8	the	the	DET
dpc-5139	40	9	jak	jak	PROPN
dpc-5139	40	10	/	/	SYM
dpc-5139	40	11	stat	stat	PROPN
dpc-5139	40	12	pathway	pathway	NOUN
dpc-5139	40	13	in	in	ADP
dpc-5139	40	14	cutaneous	cutaneous	ADJ
dpc-5139	40	15	vasculitis	vasculitis	PROPN
dpc-5139	40	16	is	be	AUX
dpc-5139	40	17	increasingly	increasingly	ADV
dpc-5139	40	18	growing	grow	VERB
dpc-5139	40	19	.	.	PUNCT
dpc-5139	41	1	several	several	ADJ
dpc-5139	41	2	studies	study	NOUN
dpc-5139	41	3	have	have	AUX
dpc-5139	41	4	reported	report	VERB
dpc-5139	41	5	the	the	DET
dpc-5139	41	6	involvement	involvement	NOUN
dpc-5139	41	7	of	of	ADP
dpc-5139	41	8	the	the	DET
dpc-5139	41	9	jak/	jak/	ADJ
dpc-5139	41	10	stat	stat	PROPN
dpc-5139	41	11	pathway	pathway	NOUN
dpc-5139	41	12	in	in	ADP
dpc-5139	41	13	anca	anca	NOUN
dpc-5139	41	14	-	-	PUNCT
dpc-5139	41	15	associated	associate	VERB
dpc-5139	41	16	vasculitis	vasculitis	PROPN
dpc-5139	42	1	[	[	X
dpc-5139	42	2	5	5	NUM
dpc-5139	42	3	]	]	PUNCT
dpc-5139	42	4	as	as	ADV
dpc-5139	42	5	well	well	ADV
dpc-5139	42	6	as	as	ADP
dpc-5139	42	7	in	in	ADP
dpc-5139	42	8	leukocytoclastic	leukocytoclastic	ADJ
dpc-5139	42	9	vasculitis	vasculitis	NOUN
dpc-5139	42	10	.	.	PUNCT
dpc-5139	43	1	indeed	indeed	ADV
dpc-5139	43	2	,	,	PUNCT
dpc-5139	43	3	ebata	ebata	NOUN
dpc-5139	43	4	et	et	PROPN
dpc-5139	43	5	al	al	PROPN
dpc-5139	43	6	.	.	PROPN
dpc-5139	43	7	recently	recently	ADV
dpc-5139	43	8	demonstrated	demonstrate	VERB
dpc-5139	43	9	,	,	PUNCT
dpc-5139	43	10	by	by	ADP
dpc-5139	43	11	immunofluorescence	immunofluorescence	NOUN
dpc-5139	43	12	,	,	PUNCT
dpc-5139	43	13	a	a	DET
dpc-5139	43	14	significantly	significantly	ADV
dpc-5139	43	15	increased	increase	VERB
dpc-5139	43	16	expression	expression	NOUN
dpc-5139	43	17	of	of	ADP
dpc-5139	43	18	phosphorylated	phosphorylate	VERB
dpc-5139	43	19	jak1	jak1	PROPN
dpc-5139	43	20	/	/	SYM
dpc-5139	43	21	jak2	jak2	PROPN
dpc-5139	43	22	in	in	ADP
dpc-5139	43	23	skin	skin	NOUN
dpc-5139	43	24	figure	figure	NOUN
dpc-5139	43	25	1	1	NUM
dpc-5139	43	26	.	.	PUNCT
dpc-5139	44	1	(	(	PUNCT
dpc-5139	44	2	a	a	DET
dpc-5139	44	3	-	-	PUNCT
dpc-5139	44	4	c	c	NOUN
dpc-5139	44	5	)	)	PUNCT
dpc-5139	44	6	clinical	clinical	ADJ
dpc-5139	44	7	appearance	appearance	NOUN
dpc-5139	44	8	at	at	ADP
dpc-5139	44	9	presentation	presentation	NOUN
dpc-5139	44	10	:	:	PUNCT
dpc-5139	44	11	wheal	wheal	ADJ
dpc-5139	44	12	-	-	PUNCT
dpc-5139	44	13	like	like	ADJ
dpc-5139	44	14	lesions	lesion	NOUN
dpc-5139	44	15	widespread	widespread	ADJ
dpc-5139	44	16	on	on	ADP
dpc-5139	44	17	the	the	DET
dpc-5139	44	18	limbs	limb	NOUN
dpc-5139	44	19	and	and	CCONJ
dpc-5139	44	20	trunk	trunk	NOUN
dpc-5139	44	21	associated	associate	VERB
dpc-5139	44	22	with	with	ADP
dpc-5139	44	23	ecchymotic	ecchymotic	ADJ
dpc-5139	44	24	hyperpigmentation	hyperpigmentation	NOUN
dpc-5139	44	25	.	.	PUNCT
dpc-5139	45	1	(	(	PUNCT
dpc-5139	45	2	d	d	X
dpc-5139	45	3	-	-	PUNCT
dpc-5139	45	4	f	f	ADJ
dpc-5139	45	5	)	)	PUNCT
dpc-5139	45	6	complete	complete	ADJ
dpc-5139	45	7	remission	remission	NOUN
dpc-5139	45	8	of	of	ADP
dpc-5139	45	9	skin	skin	NOUN
dpc-5139	45	10	lesions	lesion	NOUN
dpc-5139	45	11	after	after	ADP
dpc-5139	45	12	three	three	NUM
dpc-5139	45	13	months	month	NOUN
dpc-5139	45	14	of	of	ADP
dpc-5139	45	15	treatment	treatment	NOUN
dpc-5139	45	16	with	with	ADP
dpc-5139	45	17	upadacitinib	upadacitinib	NOUN
dpc-5139	45	18	.	.	PUNCT
dpc-5139	46	1	research	research	NOUN
dpc-5139	46	2	letter	letter	NOUN
dpc-5139	46	3	|	|	ADV
dpc-5139	46	4	dermatol	dermatol	ADJ
dpc-5139	46	5	pract	pract	NOUN
dpc-5139	46	6	concept	concept	NOUN
dpc-5139	46	7	.	.	PUNCT
dpc-5139	47	1	2025;15(2):5139	2025;15(2):5139	NUM
dpc-5139	47	2	3	3	NUM
dpc-5139	47	3	samples	sample	NOUN
dpc-5139	47	4	of	of	ADP
dpc-5139	47	5	cutaneous	cutaneous	ADJ
dpc-5139	47	6	leukocytoclastic	leukocytoclastic	ADJ
dpc-5139	47	7	vasculitis	vasculitis	NOUN
dpc-5139	47	8	compared	compare	VERB
dpc-5139	47	9	to	to	ADP
dpc-5139	47	10	healthy	healthy	ADJ
dpc-5139	47	11	controls	control	NOUN
dpc-5139	47	12	[	[	X
dpc-5139	47	13	6	6	NUM
dpc-5139	47	14	]	]	PUNCT
dpc-5139	47	15	.	.	PUNCT
dpc-5139	48	1	our	our	PRON
dpc-5139	48	2	case	case	NOUN
dpc-5139	48	3	provides	provide	VERB
dpc-5139	48	4	evidence	evidence	NOUN
dpc-5139	48	5	of	of	ADP
dpc-5139	48	6	the	the	DET
dpc-5139	48	7	promising	promising	ADJ
dpc-5139	48	8	efficacy	efficacy	NOUN
dpc-5139	48	9	of	of	ADP
dpc-5139	48	10	upadacitinib	upadacitinib	NOUN
dpc-5139	48	11	for	for	ADP
dpc-5139	48	12	the	the	DET
dpc-5139	48	13	treatment	treatment	NOUN
dpc-5139	48	14	of	of	ADP
dpc-5139	48	15	refractory	refractory	NOUN
dpc-5139	48	16	uv	uv	NOUN
dpc-5139	48	17	and	and	CCONJ
dpc-5139	48	18	also	also	ADV
dpc-5139	48	19	highlights	highlight	VERB
dpc-5139	48	20	the	the	DET
dpc-5139	48	21	potential	potential	NOUN
dpc-5139	48	22	of	of	ADP
dpc-5139	48	23	this	this	DET
dpc-5139	48	24	drug	drug	NOUN
dpc-5139	48	25	in	in	ADP
dpc-5139	48	26	cases	case	NOUN
dpc-5139	48	27	featuring	feature	VERB
dpc-5139	48	28	multiple	multiple	ADJ
dpc-5139	48	29	concomitant	concomitant	ADJ
dpc-5139	48	30	immune	immune	NOUN
dpc-5139	48	31	-	-	PUNCT
dpc-5139	48	32	mediated	mediate	VERB
dpc-5139	48	33	comorbidities	comorbiditie	NOUN
dpc-5139	48	34	,	,	PUNCT
dpc-5139	48	35	quite	quite	ADV
dpc-5139	48	36	frequent	frequent	ADJ
dpc-5139	48	37	in	in	ADP
dpc-5139	48	38	clinical	clinical	ADJ
dpc-5139	48	39	practice	practice	NOUN
dpc-5139	48	40	,	,	PUNCT
dpc-5139	48	41	thanks	thank	NOUN
dpc-5139	48	42	to	to	ADP
dpc-5139	48	43	its	its	PRON
dpc-5139	48	44	pleiotropism	pleiotropism	NOUN
dpc-5139	48	45	of	of	ADP
dpc-5139	48	46	action	action	NOUN
dpc-5139	48	47	.	.	PUNCT
dpc-5139	49	1	nevertheless	nevertheless	ADV
dpc-5139	49	2	,	,	PUNCT
dpc-5139	49	3	further	further	ADJ
dpc-5139	49	4	investigations	investigation	NOUN
dpc-5139	49	5	should	should	AUX
dpc-5139	49	6	be	be	AUX
dpc-5139	49	7	encouraged	encourage	VERB
dpc-5139	49	8	to	to	PART
dpc-5139	49	9	determine	determine	VERB
dpc-5139	49	10	the	the	DET
dpc-5139	49	11	role	role	NOUN
dpc-5139	49	12	of	of	ADP
dpc-5139	49	13	the	the	DET
dpc-5139	49	14	jak	jak	PROPN
dpc-5139	49	15	/	/	SYM
dpc-5139	49	16	stat	stat	PROPN
dpc-5139	49	17	pathway	pathway	NOUN
dpc-5139	49	18	in	in	ADP
dpc-5139	49	19	uv	uv	NOUN
dpc-5139	49	20	and	and	CCONJ
dpc-5139	49	21	the	the	DET
dpc-5139	49	22	possible	possible	ADJ
dpc-5139	49	23	effective	effective	ADJ
dpc-5139	49	24	and	and	CCONJ
dpc-5139	49	25	safe	safe	ADJ
dpc-5139	49	26	use	use	NOUN
dpc-5139	49	27	of	of	ADP
dpc-5139	49	28	jaki	jaki	PROPN
dpc-5139	49	29	in	in	ADP
dpc-5139	49	30	this	this	DET
dpc-5139	49	31	condition	condition	NOUN
dpc-5139	49	32	.	.	PUNCT
dpc-5139	50	1	references	reference	NOUN
dpc-5139	50	2	1	1	NUM
dpc-5139	50	3	.	.	PUNCT
dpc-5139	50	4	marzano	marzano	PROPN
dpc-5139	50	5	av	av	PROPN
dpc-5139	50	6	,	,	PUNCT
dpc-5139	50	7	maronese	maronese	PROPN
dpc-5139	50	8	ca	can	AUX
dpc-5139	50	9	,	,	PUNCT
dpc-5139	50	10	genovese	genovese	NOUN
dpc-5139	50	11	g	g	NOUN
dpc-5139	50	12	,	,	PUNCT
dpc-5139	50	13	et	et	PROPN
dpc-5139	50	14	al	al	PROPN
dpc-5139	50	15	.	.	PROPN
dpc-5139	51	1	urticarial	urticarial	PROPN
dpc-5139	51	2	vasculitis	vasculitis	PROPN
dpc-5139	51	3	:	:	PUNCT
dpc-5139	51	4	clinical	clinical	ADJ
dpc-5139	51	5	and	and	CCONJ
dpc-5139	51	6	laboratory	laboratory	NOUN
dpc-5139	51	7	findings	finding	NOUN
dpc-5139	51	8	with	with	ADP
dpc-5139	51	9	a	a	DET
dpc-5139	51	10	particular	particular	ADJ
dpc-5139	51	11	emphasis	emphasis	NOUN
dpc-5139	51	12	on	on	ADP
dpc-5139	51	13	differential	differential	ADJ
dpc-5139	51	14	diagnosis	diagnosis	NOUN
dpc-5139	51	15	.	.	PUNCT
dpc-5139	52	1	j	j	PROPN
dpc-5139	52	2	allergy	allergy	PROPN
dpc-5139	52	3	clin	clin	PROPN
dpc-5139	52	4	immunol	immunol	PROPN
dpc-5139	52	5	.	.	PUNCT
dpc-5139	53	1	apr	apr	PROPN
dpc-5139	53	2	2022;149(4	2022;149(4	NUM
dpc-5139	53	3	):	):	PUNCT
dpc-5139	53	4	1137	1137	NUM
dpc-5139	53	5	-	-	SYM
dpc-5139	53	6	1149	1149	NUM
dpc-5139	53	7	.	.	PUNCT
dpc-5139	54	1	doi:10.1016	doi:10.1016	PROPN
dpc-5139	54	2	/	/	SYM
dpc-5139	54	3	j.jaci.2022.02.007	j.jaci.2022.02.007	PROPN
dpc-5139	54	4	.	.	PUNCT
dpc-5139	55	1	pmid	pmid	NOUN
dpc-5139	55	2	:	:	PUNCT
dpc-5139	55	3	35396080	35396080	NUM
dpc-5139	55	4	2	2	NUM
dpc-5139	55	5	.	.	PUNCT
dpc-5139	55	6	mohamed	mohamed	PROPN
dpc-5139	55	7	mf	mf	PROPN
dpc-5139	55	8	,	,	PUNCT
dpc-5139	55	9	bhatnagar	bhatnagar	PROPN
dpc-5139	55	10	s	s	PROPN
dpc-5139	55	11	,	,	PUNCT
dpc-5139	55	12	parmentier	parmentier	PROPN
dpc-5139	55	13	jm	jm	PROPN
dpc-5139	55	14	,	,	PUNCT
dpc-5139	55	15	nakasato	nakasato	NOUN
dpc-5139	55	16	p	p	NOUN
dpc-5139	55	17	,	,	PUNCT
dpc-5139	55	18	wung	wung	PROPN
dpc-5139	55	19	p.	p.	NOUN
dpc-5139	55	20	upadacitinib	upadacitinib	NOUN
dpc-5139	55	21	:	:	PUNCT
dpc-5139	55	22	mechanism	mechanism	NOUN
dpc-5139	55	23	of	of	ADP
dpc-5139	55	24	action	action	NOUN
dpc-5139	55	25	,	,	PUNCT
dpc-5139	55	26	clinical	clinical	ADJ
dpc-5139	55	27	,	,	PUNCT
dpc-5139	55	28	and	and	CCONJ
dpc-5139	55	29	translational	translational	ADJ
dpc-5139	55	30	science	science	NOUN
dpc-5139	55	31	.	.	PUNCT
dpc-5139	56	1	clin	clin	PROPN
dpc-5139	56	2	transl	transl	PROPN
dpc-5139	56	3	sci	sci	PROPN
dpc-5139	56	4	.	.	PROPN
dpc-5139	56	5	jan	jan	PROPN
dpc-5139	56	6	2024;17(1):e13688	2024;17(1):e13688	NUM
dpc-5139	56	7	.	.	PUNCT
dpc-5139	57	1	doi:10.1111	doi:10.1111	PROPN
dpc-5139	57	2	/	/	SYM
dpc-5139	57	3	cts.13688	cts.13688	PROPN
dpc-5139	57	4	.	.	PUNCT
dpc-5139	58	1	pmid	pmid	NOUN
dpc-5139	58	2	:	:	PUNCT
dpc-5139	58	3	37984057	37984057	NUM
dpc-5139	58	4	3	3	NUM
dpc-5139	58	5	.	.	PUNCT
dpc-5139	58	6	mansouri	mansouri	PROPN
dpc-5139	58	7	p	p	PROPN
dpc-5139	58	8	,	,	PUNCT
dpc-5139	58	9	mozafari	mozafari	ADJ
dpc-5139	58	10	n	n	CCONJ
dpc-5139	58	11	,	,	PUNCT
dpc-5139	58	12	chalangari	chalangari	ADJ
dpc-5139	58	13	r	r	NOUN
dpc-5139	58	14	,	,	PUNCT
dpc-5139	58	15	martits	martit	NOUN
dpc-5139	58	16	-	-	PUNCT
dpc-5139	58	17	chalangari	chalangari	ADJ
dpc-5139	58	18	k.	k.	PROPN
dpc-5139	58	19	efficacy	efficacy	PROPN
dpc-5139	58	20	of	of	ADP
dpc-5139	58	21	oral	oral	ADJ
dpc-5139	58	22	tofacitinib	tofacitinib	NOUN
dpc-5139	58	23	in	in	ADP
dpc-5139	58	24	refractory	refractory	NOUN
dpc-5139	58	25	chronic	chronic	ADJ
dpc-5139	58	26	spontaneous	spontaneous	ADJ
dpc-5139	58	27	urticaria	urticaria	NOUN
dpc-5139	58	28	and	and	CCONJ
dpc-5139	58	29	urticarial	urticarial	ADJ
dpc-5139	58	30	vasculitis	vasculitis	PROPN
dpc-5139	58	31	.	.	PUNCT
dpc-5139	59	1	dermatol	dermatol	NOUN
dpc-5139	59	2	ther	ther	ADV
dpc-5139	59	3	.	.	PUNCT
dpc-5139	60	1	dec	dec	PROPN
dpc-5139	60	2	2022;35(12):e15932	2022;35(12):e15932	PROPN
dpc-5139	60	3	.	.	PUNCT
dpc-5139	60	4	doi:10.1111	doi:10.1111	ADJ
dpc-5139	60	5	/	/	SYM
dpc-5139	60	6	dth.15932	dth.15932	NOUN
dpc-5139	60	7	.	.	PUNCT
dpc-5139	61	1	pmid	pmid	NOUN
dpc-5139	61	2	:	:	PUNCT
dpc-5139	61	3	36226796	36226796	NUM
dpc-5139	61	4	4	4	NUM
dpc-5139	61	5	.	.	PUNCT
dpc-5139	62	1	zhu	zhu	PROPN
dpc-5139	62	2	kj	kj	PROPN
dpc-5139	62	3	,	,	PUNCT
dpc-5139	62	4	yang	yang	PROPN
dpc-5139	62	5	pd	pd	PROPN
dpc-5139	62	6	,	,	PUNCT
dpc-5139	62	7	xu	xu	PROPN
dpc-5139	62	8	q.	q.	PROPN
dpc-5139	62	9	tofacitinib	tofacitinib	PROPN
dpc-5139	62	10	treatment	treatment	NOUN
dpc-5139	62	11	of	of	ADP
dpc-5139	62	12	refractory	refractory	NOUN
dpc-5139	62	13	cutaneous	cutaneous	ADJ
dpc-5139	62	14	leukocytoclastic	leukocytoclastic	ADJ
dpc-5139	62	15	vasculitis	vasculitis	NOUN
dpc-5139	62	16	:	:	PUNCT
dpc-5139	62	17	a	a	DET
dpc-5139	62	18	case	case	NOUN
dpc-5139	62	19	report	report	NOUN
dpc-5139	62	20	.	.	PUNCT
dpc-5139	63	1	front	front	ADJ
dpc-5139	63	2	immunol	immunol	NOUN
dpc-5139	63	3	.	.	PUNCT
dpc-5139	64	1	2021;12:695768	2021;12:695768	NUM
dpc-5139	64	2	.	.	X
dpc-5139	64	3	doi:10.3389	doi:10.3389	PROPN
dpc-5139	64	4	/	/	SYM
dpc-5139	64	5	fimmu.2021.695768	fimmu.2021.695768	PROPN
dpc-5139	64	6	.	.	PUNCT
dpc-5139	65	1	pmid	pmid	NOUN
dpc-5139	65	2	:	:	PUNCT
dpc-5139	65	3	34248994	34248994	NUM
dpc-5139	65	4	5	5	NUM
dpc-5139	65	5	.	.	PUNCT
dpc-5139	66	1	rathore	rathore	PROPN
dpc-5139	66	2	u	u	PROPN
dpc-5139	66	3	,	,	PUNCT
dpc-5139	66	4	thakare	thakare	PROPN
dpc-5139	66	5	dr	dr	PROPN
dpc-5139	66	6	,	,	PUNCT
dpc-5139	66	7	patro	patro	VERB
dpc-5139	66	8	p	p	NOUN
dpc-5139	66	9	,	,	PUNCT
dpc-5139	66	10	agarwal	agarwal	PROPN
dpc-5139	66	11	v	v	PROPN
dpc-5139	66	12	,	,	PUNCT
dpc-5139	66	13	sharma	sharma	PROPN
dpc-5139	66	14	a	a	DET
dpc-5139	66	15	,	,	PUNCT
dpc-5139	66	16	misra	misra	ADJ
dpc-5139	66	17	dp	dp	NOUN
dpc-5139	66	18	.	.	PUNCT
dpc-5139	67	1	a	a	DET
dpc-5139	67	2	systematic	systematic	ADJ
dpc-5139	67	3	review	review	NOUN
dpc-5139	67	4	of	of	ADP
dpc-5139	67	5	clinical	clinical	ADJ
dpc-5139	67	6	and	and	CCONJ
dpc-5139	67	7	preclinical	preclinical	ADJ
dpc-5139	67	8	evidences	evidence	NOUN
dpc-5139	67	9	for	for	ADP
dpc-5139	67	10	janus	janus	PROPN
dpc-5139	67	11	kinase	kinase	PROPN
dpc-5139	67	12	inhibitors	inhibitor	NOUN
dpc-5139	67	13	in	in	ADP
dpc-5139	67	14	large	large	ADJ
dpc-5139	67	15	vessel	vessel	NOUN
dpc-5139	67	16	vasculitis	vasculitis	PROPN
dpc-5139	67	17	.	.	PUNCT
dpc-5139	68	1	clin	clin	PROPN
dpc-5139	68	2	rheumatol	rheumatol	PROPN
dpc-5139	68	3	.	.	PUNCT
dpc-5139	69	1	jan	jan	PROPN
dpc-5139	69	2	2022;41(1):33	2022;41(1):33	NUM
dpc-5139	69	3	-	-	SYM
dpc-5139	69	4	44	44	NUM
dpc-5139	69	5	.	.	PUNCT
dpc-5139	70	1	doi:10.1007	doi:10.1007	NOUN
dpc-5139	70	2	/	/	SYM
dpc-5139	70	3	s10067	s10067	NOUN
dpc-5139	70	4	-	-	PUNCT
dpc-5139	70	5	021	021	NUM
dpc-5139	70	6	-05973	-05973	PROPN
dpc-5139	70	7	-	-	PUNCT
dpc-5139	70	8	4	4	NUM
dpc-5139	70	9	.	.	PUNCT
dpc-5139	71	1	pmid	pmid	NOUN
dpc-5139	71	2	:	:	PUNCT
dpc-5139	71	3	34729652	34729652	NUM
dpc-5139	71	4	6	6	NUM
dpc-5139	71	5	.	.	PUNCT
dpc-5139	72	1	ebata	ebata	PROPN
dpc-5139	72	2	a	a	PRON
dpc-5139	72	3	,	,	PUNCT
dpc-5139	72	4	ogawa	ogawa	PROPN
dpc-5139	72	5	-	-	PUNCT
dpc-5139	72	6	momohara	momohara	PROPN
dpc-5139	72	7	m	m	PROPN
dpc-5139	72	8	,	,	PUNCT
dpc-5139	72	9	fukaura	fukaura	NOUN
dpc-5139	72	10	r	r	NOUN
dpc-5139	72	11	,	,	PUNCT
dpc-5139	72	12	et	et	PROPN
dpc-5139	72	13	al	al	PROPN
dpc-5139	72	14	.	.	PROPN
dpc-5139	72	15	increased	increase	VERB
dpc-5139	72	16	janus	janus	PROPN
dpc-5139	72	17	kinase	kinase	PROPN
dpc-5139	72	18	activation	activation	NOUN
dpc-5139	72	19	in	in	ADP
dpc-5139	72	20	cutaneous	cutaneous	ADJ
dpc-5139	72	21	vasculitis	vasculitis	PROPN
dpc-5139	72	22	.	.	PUNCT
dpc-5139	73	1	j	j	PROPN
dpc-5139	73	2	am	be	AUX
dpc-5139	73	3	acad	acad	ADJ
dpc-5139	73	4	dermatol	dermatol	NOUN
dpc-5139	73	5	.	.	PUNCT
dpc-5139	74	1	mar	mar	PROPN
dpc-5139	74	2	2024;90(3):627	2024;90(3):627	PROPN
dpc-5139	74	3	-	-	PUNCT
dpc-5139	74	4	629	629	NUM
dpc-5139	74	5	.	.	PUNCT
dpc-5139	74	6	doi:10.1016	doi:10.1016	PROPN
dpc-5139	74	7	/	/	SYM
dpc-5139	74	8	j.jaad.2023.10.056	j.jaad.2023.10.056	PROPN
dpc-5139	74	9	.	.	PUNCT
dpc-5139	75	1	pmid	pmid	PROPN
dpc-5139	75	2	:	:	PUNCT
dpc-5139	75	3	37924954	37924954	NUM